BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...
LONDON--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, announced today that the first EKOS™ CU 4.0 units have been shipped from BTG’s facility in Bothell (Washington, US) to ...
The danger in someone with the condition of deep vein thrombosis is that a portion of a blood clot that predominately forms in the leg could break off and travel to the patient’s lungs causing a ...
A new angiographic service has been launched which uses mechanical and chemical techniques to break down blood clots that block the major arteries of the lungs. This was announced by the Minister ...
Boston Scientific, a Marlborough-based biomedical life sciences firm, is using electronic health records from 80 million U.S. patients to inform a new study into pulmonary embolism. PE is a ...
A new study using Boston Scientific's EkoSonic endovascular system (EKOS) aims to address current gaps in clinical guidelines for the treatment of pulmonary embolism. The first-of-its-kind trial will ...
Standard clot-busting medication combined with low-energy ultrasound appears to reopen clogged arteries in stroke patients better than medication alone, a pilot study led by University of Cincinnati ...
His doctor says a device that's revolutionizing the way he attacks clots may have saved the patient's life. Two and a half feet! That's how big the blood clot was in Gerry Cunha's body. "I just couldn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback